De medische bronnen van Healthway.

Bronnen.

1. Nieren

  • Grams ME, Sang Y, Ballew SH, Gansevoort RT, Kimm H, Kovesdy CP, et al. A meta-analysis of the association of estimated GFR, albuminuria, age, race, and sex with acute kidney injury. Am J Kidney Dis [Internet]. 2015 [cited 2023 Oct 19];66(4):591–601. Available from: https://pubmed.ncbi.nlm.nih.gov/25943717

  • Jia F, Li X, Liu F, Shi X, Liu H, Cao F. Association of renal function and depressive symptoms: Evidence from the China health and retirement longitudinal study. J Psychosom Res [Internet]. 2020;137(110224):110224. Available from: http://dx.doi.org/10.1016/j.jpsychores.2020.110224

  • Jhee JH, Lee E, Cha M-U, Lee M, Kim H, Park S, et al. Prevalence of depression and suicidal ideation increases proportionally with renal function decline, beginning from early stages of chronic kidney disease. Medicine (Baltimore) [Internet]. 2017;96(44):e8476. Available from: http://dx.doi.org/10.1097/md.0000000000008476

  • Canney M, Sexton E, Tobin K, Kenny RA, Little MA, O’Seaghdha CM. The relationship between kidney function and quality of life among community-dwelling adults varies by age and filtration marker. Clin Kidney J [Internet]. 2018;11(2):259–64. Available from: http://dx.doi.org/10.1093/ckj/sfx084

  • Coresh J, Turin TC, Matsushita K, Sang Y, Ballew SH, Appel LJ, et al. Decline in estimated glomerular filtration rate and subsequent risk of end-stage renal disease and mortality. JAMA [Internet]. 2014 [cited 2023 Oct 19];311(24):2518. Available from: https://pubmed.ncbi.nlm.nih.gov/24892770

  • Iff S, Craig JC, Turner R, Chapman JR, Wang JJ, Mitchell P, et al. Reduced estimated GFR and cancer mortality. Am J Kidney Dis [Internet]. 2014 [cited 2023 Oct 19];63(1):23–30. Available from: https://pubmed.ncbi.nlm.nih.gov/23993153

  • Wong G, Hayen A, Chapman JR, Webster AC, Wang JJ, Mitchell P, et al. Association of CKD and cancer risk in older people. J Am Soc Nephrol [Internet]. 2009 [cited 2023 Oct 19];20(6):1341–50. Available from: https://pubmed.ncbi.nlm.nih.gov/19406977

  • Chen DP, Davis BR, Simpson LM, Cushman WC, Cutler JA, Dobre M, et al. Association between chronic kidney disease and cancer mortality: A report from the ALLHAT. Clin Nephrol [Internet]. 2017 [cited 2023 Oct 19];87(01):11–20. Available from: https://pubmed.ncbi.nlm.nih.gov/27900942

  • Wakasugi M, Narita I, Iseki K, Asahi K, Yamagata K, Fujimoto S, et al. The effect of CKD on associations between lifestyle factors and all-cause, cancer, and cardiovascular mortality: A population-based cohort study. Intern Med [Internet]. 2021 [cited 2023 Oct 19];60(14):2189–200. Available from: https://pubmed.ncbi.nlm.nih.gov/33583896

  • Matsushita K, Selvin E, Bash LD, Franceschini N, Astor BC, Coresh J. Change in estimated GFR associates with coronary heart disease and mortality. J Am Soc Nephrol [Internet]. 2009 [cited 2023 Oct 19];20(12):2617–24. Available from: https://pubmed.ncbi.nlm.nih.gov/19892932

  • Ku E, Xie D, Shlipak M, Hyre Anderson A, Chen J, Go AS, et al. Change in measured GFR versus eGFR and CKD outcomes. J Am Soc Nephrol [Internet]. 2016 [cited 2023 Oct 19];27(7):2196–204. Available from: https://pubmed.ncbi.nlm.nih.gov/26604213

  • Oshima M, on behalf of the ADVANCE Collaborative Group, Jun M, Ohkuma T, Toyama T, Wada T, et al. The relationship between eGFR slope and subsequent risk of vascular outcomes and all-cause mortality in type 2 diabetes: the ADVANCE-ON study. Diabetologia [Internet]. 2019;62(11):1988–97. Available from: http://dx.doi.org/10.1007/s00125-019-4948-4

  • Shlipak MG, Katz R, Kestenbaum B, Siscovick D, Fried L, Newman A, et al. Rapid decline of kidney function increases cardiovascular risk in the elderly. J Am Soc Nephrol [Internet]. 2009 [cited 2023 Oct 19];20(12):2625–30. Available from: https://pubmed.ncbi.nlm.nih.gov/19892934

2. Hart en vaat

  • Madsen CM, Varbo A, Nordestgaard BG. Extreme high high-density lipoprotein cholesterol is paradoxically associated with high mortality in men and women: two prospective cohort studies. Eur Heart J [Internet]. 2017 [cited 2023 Oct 19];38(32):2478–86. Available from: https://academic.oup.com/eurheartj/article/38/32/2478/3608700

  • Li H, Qian F, Zuo Y, Yuan J, Chen S, Wu S, et al. U-shaped relationship of high-density lipoprotein cholesterol and incidence of total, ischemic and hemorrhagic stroke: A prospective cohort study. Stroke [Internet]. 2022;53(5):1624–32. Available from: http://dx.doi.org/10.1161/strokeaha.121.034393

  • Chen Z-M, Gu H-Q, Mo J-L, Yang K-X, Jiang Y-Y, Yang X, et al. U-shaped association between low-density lipoprotein cholesterol levels and risk of all-cause mortality mediated by post-stroke infection in acute ischemic stroke. Sci Bull (Beijing) [Internet]. 2023;68(12):1327–35. Available from: https://www.sciencedirect.com/science/article/pii/S209592732300347X

  • Sung, Huh, Ryu, Lee, Scorletti, Byrne, et al. Low levels of low-density lipoprotein cholesterol and mortality outcomes in non-statin users. J Clin Med [Internet]. 2019 [cited 2023 Oct 19];8(10):1571. Available from: https://www.mdpi.com/2077-0383/8/10/1571

  • Penson PE, Pirro M, Banach M. LDL-C: lower is better for longer—even at low risk. BMC Med [Internet]. 2020;18(1). Available from: http://dx.doi.org/10.1186/s12916-020-01792-7

  • Johannesen CDL, Langsted A, Mortensen MB, Nordestgaard BG. Association between low density lipoprotein and all cause and cause specific mortality in Denmark: prospective cohort study. BMJ [Internet]. 2020 [cited 2023 Oct 19];371:m4266. Available from: http://dx.doi.org/10.1136/bmj.m4266

  • Wilkins JT, Ning H, Stone NJ, Criqui MH, Zhao L, Greenland P, et al. Coronary heart disease risks associated with high levels of HDL cholesterol. J Am Heart Assoc [Internet]. 2014 [cited 2023 Oct 19];3(2). Available from: http://dx.doi.org/10.1161/jaha.113.000519

  • Jung E, Kong SY, Ro YS, Ryu HH, Shin SD. Serum cholesterol levels and risk of cardiovascular death: A systematic review and a dose-response meta-analysis of prospective cohort studies. Int J Environ Res Public Health [Internet]. 2022 [cited 2023 Oct 19];19(14):8272. Available from: https://www.mdpi.com/1660-4601/19/14/8272

  • Huh JH, Park SW, Go T-H, Kang DR, Lee S-H, Kim J-Y. Optimal low-density lipoprotein cholesterol levels in adults without diabetes mellitus: A nationwide population-based study including more than 4 million individuals from South Korea. Front Cardiovasc Med [Internet]. 2022;8. Available from: http://dx.doi.org/10.3389/fcvm.2021.812416

  • Shin H-Y, Kang G, Kang H-J, Kim S-W, Shin I-S, Yoon J-S, et al. Associations between serum lipid levels and suicidal ideation among Korean older people. J Affect Disord [Internet]. 2016;189:192–8. Available from: https://www.sciencedirect.com/science/article/pii/S0165032715306029

  • Huxley R, Lewington S, Clarke R. Cholesterol, coronary heart disease and stroke: A review of published evidence from observational studies and randomized controlled trials. Semin Vasc Med [Internet]. 2002;02(3):315–24. Available from: http://dx.doi.org/10.1055/s-2002-35402

  • Abdullah SM, Defina LF, Leonard D, Barlow CE, Radford NB, Willis BL, et al. Long-term association of low-density lipoprotein cholesterol with cardiovascular mortality in individuals at low 10-year risk of atherosclerotic cardiovascular disease: Results from the Cooper Center Longitudinal Study. Circulation [Internet]. 2018;138(21):2315–25. Available from: http://dx.doi.org/10.1161/circulationaha.118.034273

  • Howard BV, Robbins DC, Sievers ML, Lee ET, Rhoades D, Devereux RB, et al. LDL cholesterol as a strong predictor of coronary heart disease in diabetic individuals with insulin resistance and low LDL: The Strong Heart Study. Arterioscler Thromb Vasc Biol [Internet]. 2000;20(3):830–5. Available from: http://dx.doi.org/10.1161/01.atv.20.3.830

  • Mortensen MB, Nordestgaard BG. Elevated LDL cholesterol and increased risk of myocardial infarction and atherosclerotic cardiovascular disease in individuals aged 70–100 years: a contemporary primary prevention cohort. Lancet [Internet]. 2020;396(10263):1644–52. Available from: http://dx.doi.org/10.1016/s0140-6736(20)32233-9

3. Bloedsuiker

  • Silbernagel G, Grammer TB, Winkelmann BR, Boehm BO, März W. Glycated hemoglobin predicts all-cause, cardiovascular, and cancer mortality in people without a history of diabetes undergoing coronary angiography. Diabetes Care [Internet]. 2011;34(6):1355–61. Available from: http://dx.doi.org/10.2337/dc10-2010

  • Kim GS, Oh HH, Kim SH, Kim BO, Byun YS. Association between prediabetes (defined by HbA1C, fasting plasma glucose, and impaired glucose tolerance) and the development of chronic kidney disease: a 9-year prospective cohort study. BMC Nephrol [Internet]. 2019;20(1). Available from: http://dx.doi.org/10.1186/s12882-019-1307-0

  • Joshu CE, Prizment AE, Dluzniewski PJ, Menke A, Folsom AR, Coresh J, et al. Glycated hemoglobin and cancer incidence and mortality in the Atherosclerosis in Communities (ARIC) Study, 1990–2006. Int J Cancer [Internet]. 2012;131(7):1667–77. Available from: http://dx.doi.org/10.1002/ijc.27394

  • Khaw K-T, Wareham N, Bingham S, Luben R, Welch A, Day N. Association of hemoglobin A1c with cardiovascular disease and mortality in adults: The European prospective investigation into cancer in Norfolk. Ann Intern Med [Internet]. 2004;141(6):413. Available from: http://dx.doi.org/10.7326/0003-4819-141-6-200409210-00006

  • Hope C, Robertshaw A, Cheung KL, Idris I, English E. Relationship between HbA1c and cancer in people with or without diabetes: a systematic review. Diabet Med [Internet]. 2016;33(8):1013–25. Available from: http://dx.doi.org/10.1111/dme.13031

  • Jing X, Chen J, Dong Y, Han D, Zhao H, Wang X, et al. Related factors of quality of life of type 2 diabetes patients: a systematic review and meta-analysis. Health Qual Life Outcomes [Internet]. 2018;16(1). Available from: http://dx.doi.org/10.1186/s12955-018-1021-9

  • Schöttker B, on behalf of the CHANCES group, Rathmann W, Herder C, Thorand B, Wilsgaard T, et al. HbA1c levels in non-diabetic older adults – No J-shaped associations with primary cardiovascular events, cardiovascular and all-cause mortality after adjustment for confounders in a meta-analysis of individual participant data from six cohort studies. BMC Med [Internet]. 2016;14(1). Available from: http://dx.doi.org/10.1186/s12916-016-0570-1

  • Zhong G-C, Ye M-X, Cheng J-H, Zhao Y, Gong J-P. HbA1c and risks of all-cause and cause-specific death in subjects without known diabetes: A dose-response meta-analysis of prospective cohort studies. Sci Rep [Internet]. 2016;6(1). Available from: http://dx.doi.org/10.1038/srep24071

  • Chiu C-J, Wray LA, Beverly EA, Dominic OG. The role of health behaviors in mediating the relationship between depressive symptoms and glycemic control in type 2 diabetes: a structural equation modeling approach. Soc Psychiatry Psychiatr Epidemiol [Internet]. 2010;45(1):67–76. Available from: http://dx.doi.org/10.1007/s00127-009-0043-3

  • Goto A, Noda M, Sawada N, Kato M, Hidaka A, Mizoue T, et al. High hemoglobin A1c levels within the non‐diabetic range are associated with the risk of all cancers. Int J Cancer [Internet]. 2016;138(7):1741–53. Available from: http://dx.doi.org/10.1002/ijc.29917

  • de Beer JC, Liebenberg L. Does cancer risk increase with HbA1c, independent of diabetes? Br J Cancer [Internet]. 2014;110(9):2361–8. Available from: http://dx.doi.org/10.1038/bjc.2014.150

4. Ontstekingen

  • Schöttker B, on behalf of the CHANCES group, Rathmann W, Herder C, Thorand B, Wilsgaard T, et al. HbA1c levels in non-diabetic older adults – No J-shaped associations with primary cardiovascular events, cardiovascular and all-cause mortality after adjustment for confounders in a meta-analysis of individual participant data from six cohort studies. BMC Med [Internet]. 2016;14(1). Available from: http://dx.doi.org/10.1186/s12916-016-0570-1

  • Carrero JJ, Andersson Franko M, Obergfell A, Gabrielsen A, Jernberg T. HsCRP level and the risk of death or recurrent cardiovascular events in patients with myocardial infarction: A healthcare‐based study. J Am Heart Assoc [Internet]. 2019;8(11). Available from: http://dx.doi.org/10.1161/jaha.119.012638

  • Nowakowski ACH. Chronic inflammation and quality of life in older adults: a cross-sectional study using biomarkers to predict emotional and relational outcomes. Health Qual Life Outcomes [Internet]. 2014;12(1). Available from: http://dx.doi.org/10.1186/s12955-014-0141-0

  • Yuan N, Chen Y, Xia Y, Dai J, Liu C. Inflammation-related biomarkers in major psychiatric disorders: a cross-disorder assessment of reproducibility and specificity in 43 meta-analyses. Transl Psychiatry [Internet]. 2019;9(1). Available from: http://dx.doi.org/10.1038/s41398-019-0570-y

  • Arima H, Kubo M, Yonemoto K, Doi Y, Ninomiya T, Tanizaki Y, et al. High-sensitivity C-reactive protein and coronary heart disease in a general population of Japanese: The Hisayama study. Arterioscler Thromb Vasc Biol [Internet]. 2008;28(7):1385–91. Available from: http://dx.doi.org/10.1161/atvbaha.107.157164

  • Boekholdt SM, Hack CE, Sandhu MS, Luben R, Bingham SA, Wareham NJ, et al. C-reactive protein levels and coronary artery disease incidence and mortality in apparently healthy men and women: The EPIC-Norfolk prospective population study 1993–2003. Atherosclerosis [Internet]. 2006 [cited 2023 Oct 19];187(2):415–22. Available from: https://pubmed.ncbi.nlm.nih.gov/16257408

  • Danesh J, Wheeler JG, Hirschfield GM, Eda S, Eiriksdottir G, Rumley A, et al. C-reactive protein and other circulating markers of inflammation in the prediction of coronary heart disease. N Engl J Med [Internet]. 2004 [cited 2023 Oct 19];350(14):1387–97. Available from: https://pubmed.ncbi.nlm.nih.gov/15070788

  • Pai JK, Pischon T, Ma J, Manson JE, Hankinson SE, Joshipura K, et al. Inflammatory markers and the risk of coronary heart disease in men and women. N Engl J Med [Internet]. 2004 [cited 2023 Oct 19];351(25):2599–610. Available from: https://pubmed.ncbi.nlm.nih.gov/15602020

  • Luc G, Bard J-M, Juhan-Vague I, Ferrieres J, Evans A, Amouyel P, et al. C-reactive protein, interleukin-6, and fibrinogen as predictors of coronary heart disease: The PRIME study. Arterioscler Thromb Vasc Biol [Internet]. 2003 [cited 2023 Oct 19];23(7):1255–61. Available from: https://pubmed.ncbi.nlm.nih.gov/12775578

  • Ridker PM, Rifai N, Rose L, Buring JE, Cook NR. Comparison of C-reactive protein and low-density lipoprotein cholesterol levels in the prediction of first cardiovascular events. N Engl J Med [Internet]. 2002 [cited 2023 Oct 19];347(20):1557–65. Available from: https://pubmed.ncbi.nlm.nih.gov/12432042

  • Folsom AR, Aleksic N, Catellier D, Juneja HS, Wu KK. C-reactive protein and incident coronary heart disease in the Atherosclerosis Risk In Communities (ARIC) study. Am Heart J [Internet]. 2002 [cited 2023 Oct 19];144(2):233–8. Available from: https://pubmed.ncbi.nlm.nih.gov/12177639

  • Ridker PM, Cushman M, Stampfer MJ, Tracy RP, Hennekens CH. Inflammation, aspirin, and the risk of cardiovascular disease in apparently healthy men. N Engl J Med [Internet]. 1997 [cited 2023 Oct 19];336(14):973–9. Available from: https://pubmed.ncbi.nlm.nih.gov/9077376

  • Zuo H, Ueland PM, Ulvik A, Eussen SJPM, Vollset SE, Nygård O, et al. Plasma biomarkers of inflammation, the kynurenine pathway, and risks of all-cause, cancer, and cardiovascular disease mortality: The hordaland health study. Am J Epidemiol [Internet]. 2016 [cited 2023 Oct 19];183(4):249–58. Available from: https://pubmed.ncbi.nlm.nih.gov/26823439

  • Kaura A, Hartley A, Panoulas V, Glampson B, Davies J, Mulla A, et al. 145 The role of high-sensitivity C-reactive protein in predicting mortality beyond troponin in over 100,000 patients with suspected acute coronary syndrome (NIHR Health Informatics Collaborative CRP-risk Study). In: Acute Coronary Syndromes. BMJ Publishing Group Ltd and British Cardiovascular Society; 2019

  • Lee S-A, Kwon SO, Park H, Shu X-O, Lee J-K, Kang D. Association of serum high-sensitivity C reactive protein with risk of mortality in an Asian population: the Health Examinees cohort. BMJ Open [Internet]. 2022;12(7):e052630. Available from: http://dx.doi.org/10.1136/bmjopen-2021-052630

  • Bohula EA, Giugliano RP, Leiter LA, Verma S, Park J-G, Sever PS, et al. Inflammatory and cholesterol risk in the FOURIER trial. Circulation [Internet]. 2018;138(2):131–40. Available from: http://dx.doi.org/10.1161/circulationaha.118.034032

  • Chen Z-M, Gu H-Q, Mo J-L, Yang K-X, Jiang Y-Y, Yang X, et al. U-shaped association between low-density lipoprotein cholesterol levels and risk of all-cause mortality mediated by post-stroke infection in acute ischemic stroke. Sci Bull (Beijing) [Internet]. 2023;68(12):1327–35. Available from: http://dx.doi.org/10.1016/j.scib.2023.05.028

Voordelen.

Met onze tests heeft u de middelen om op data gebaseerde beslissingen te nemen en de gezondheid van uw deelnemers nauwkeurig te volgen.

Datagedreven doelen.

Ons platform is ontworpen voor eenvoudige bestellingen en snelle resultaten, zodat u zich kunt concentreren op wat echt belangrijk is: het welzijn van uw deelnemers.

Makkelijk voor u.

Potentiële risico's vroegtijdig identificeren en proactief handelen voor optimale gezondheid.

Screening.